Teva- Pharmaceutical Industries Overview

Teva- Pharmaceutical Industries Total Revenue

Revenue analysis for TEVA.

Quarterly Revenue

$3.98B

↑ 2.31% YoY

As of Mar 2026

Annual Revenue (TTM)

$17.35B

↑ 4.42% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin